Johnson & Johnson (JNJ)

140.60
+0.24(+0.17%)
  • Volume:
    8,411
  • Bid/Ask:
    140.38/140.60
  • Day's Range:
    139.26 - 141.28
  • Type:Equity
  • Market:Germany
  • ISIN:US4781601046
  • WKN:853260

JNJ Overview

Prev. Close
140.36
Day's Range
139.26-141.28
Revenue
77.53B
Open
141.04
52 wk Range
115.74-153.98
EPS
-
Volume
8,411
Market Cap
370.16B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
8,702
P/E Ratio
-
Beta
-
1-Year Change
14.64%
Shares Outstanding
2,632,482,092
Next Earnings Date
-
What is your sentiment on Johnson & Johnson Co.?
or
Market is currently closed. Voting is open during market hours.

Johnson & Johnson Co. News

Johnson & Johnson Co. Analysis

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesBuyBuyBuy
Technical IndicatorsStrong BuyStrong SellStrong Buy
SummaryStrong BuyNeutralStrong Buy

Johnson & Johnson Co. Company Profile

Johnson & Johnson Co. Company Profile

Employees
134500

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.

Read More
  • BB squeezing now, make your read...
    0
    • even if they maintain their EPS at 10/year, this stock has a future PE of 16-17, extremely cheap with respect to other sectors and the market overall (including tech).
      1
      • Is there any new info regarding the HIV vaccine?
        0
        • JNJ announced data from a phase IIb HIV vaccine study, which showed that its vaccine candidate did not provide a sufficient level of protection against HIV infection in young women in sub-Saharan Africa.
          0
      • Not enough to make a profit. JNJ made up the numbers, but the return is actually negative.
        3
        • made up the numbers?
          0
        • go back to WSB
          0
      • What do you think about the results? EPS and revenue above and slightly below expectations, respectively
        0
        • @ 157.69 bought 3 million shares.!-)))) hehehehehe.....last 5' ......
          4
          • Ciprian Galești Român?
            0
          • Ciprian Gal Ciprian from Cyprus Mr. Gal what is your opinion please where the price will jump please ?
            0
          • da
            0
        • don't sell Friday @ 170.00  usd .
          1
          • No impact of a ready plant shutdown before it starts in Hyderabad India. Stock is still near to high..
            0
            • Please explain...?
              1
            • @ Shailendra Gour Dear Gentleman can you analyze please ? best regards, Alexander The Great from Greece .
              0
          • Time to go back up?
            1
            • It's time to buy more before it fill the gap from dividends.
              0
              • Time to buy more!!!
                0
                • Buy the dip or mis the 180-185$ range end of September...
                  0
                  • Looking at 1-year graph, I agree with you
                    0
                  • Bought few
                    0
                • Cheaper now, time to buy more? It’s a growing company anyway
                  1
                  • what's happening?
                    0
                    • Overall trend is still a bullish.
                      0
                      • Bullish
                        1
                        • double top + engulfing... very bearish
                          0
                          • Will start to buy at 160 for long term
                            0
                            • dont buy now. Wait till next week. currently weekly chart form bearish engulfing.
                              0
                              • Time to buy...
                                0
                                • Should I buy JNJ at this time?
                                  0
                                  • Should I buy JNJ at this time?
                                    0
                                    • Should I buy JNJ at this time?
                                      0
                                      • A technical formation shows 192 USD target, but not sure (like nothing on the stock market 😃)
                                        0
                                      • Today I will buy 200 shares
                                        0
                                    • should look at evfm! non hormone birth control sales up 100% only use when needed for birth control...no pills
                                      0
                                      • https://www.cnbc.com/2021/07/21/drug-distributors-jj-reach-landmark-26-billion-opioid-settlement-.html
                                        0
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.